Variation in effectiveness of planned postpartum contraception at two time points from prenatal to postpartum care.
Contraceptive counseling
Decision-making
Disparity
Postpartum contraception
Journal
Contraception
ISSN: 1879-0518
Titre abrégé: Contraception
Pays: United States
ID NLM: 0234361
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
24
01
2020
revised:
01
06
2020
accepted:
03
06
2020
pubmed:
17
6
2020
medline:
21
9
2021
entrez:
17
6
2020
Statut:
ppublish
Résumé
To identify characteristics of women who have consistent plans in terms of contraceptive effectiveness from antepartum to postpartum care. This is a secondary analysis of a retrospective chart review of women who delivered at a single tertiary care center from 2012 to 2014. Preferred postpartum contraceptive plan was abstracted at three time points (prenatal care, hospital discharge, and outpatient postpartum care) and categorized into three tiers of effectiveness. We then examined consistency between the first two time points for the effectiveness in postpartum contraceptive method planned. Of the 8,394 women in the study cohort, 2,642 (31.5%) had a consistent postpartum contraceptive plan. Women who had a consistent plan were more likely to have higher parity (aOR 2.36, 95% CI 2.06-2.70 for parity 2+), choose highly effective methods of contraception (p < 0.001), achieve their contraception plan (adjusted odds ratio [aOR] 2.16, 95% confidence interval [95% CI] 1.85-2.52), but not more likely to have a subsequent pregnancy within 365 days of delivery (aOR 0.92, 95% CI 0.81-1.05). Better understanding contraceptive decision-making as a journey and removing external barriers during that process is a necessary component of pregnancy care. Counseling and documentation of contraceptive preferences throughout antepartum and postpartum care can help improve contraceptive outcomes.
Identifiants
pubmed: 32540241
pii: S0010-7824(20)30178-5
doi: 10.1016/j.contraception.2020.06.002
pmc: PMC7572620
mid: NIHMS1603579
pii:
doi:
Substances chimiques
Contraceptive Agents, Female
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
246-250Subventions
Organisme : NCATS NIH HHS
ID : KL2 TR002547
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Références
Am J Obstet Gynecol. 2017 Jul;217(1):55.e1-55.e9
pubmed: 28257962
J Adolesc Health. 2013 Apr;52(4 Suppl):S47-53
pubmed: 23535057
BMC Womens Health. 2017 Apr 04;17(1):25
pubmed: 28376779
J Pediatr Adolesc Gynecol. 2015 Feb;28(1):24-28
pubmed: 25444052
Perspect Sex Reprod Health. 2017 Sep;49(3):149-156
pubmed: 28419700
Am J Obstet Gynecol. 2015 Jul;213(1):46.e1-46.e6
pubmed: 25644443
Contraception. 2019 Jan;99(1):32-35
pubmed: 30194927
Womens Health Issues. 2015 Nov-Dec;25(6):622-7
pubmed: 26253826
Cochrane Database Syst Rev. 2014 Nov 27;(11):CD011298
pubmed: 25429714
J Adolesc Health. 2016 Jun;58(6):628-35
pubmed: 26852250
Obstet Gynecol. 2017 Sep;130(3):609-615
pubmed: 28796678
Obstet Gynecol. 2019 Dec;134(6):1171-1177
pubmed: 31764726
Contraception. 2004 Nov;70(5):383-6
pubmed: 15504377
Womens Health Issues. 2017 Sep - Oct;27(5):539-545
pubmed: 28412049
Perspect Sex Reprod Health. 2012 Sep;44(3):194-200
pubmed: 22958664
Womens Health Issues. 2015 Nov-Dec;25(6):616-21
pubmed: 26212318
J Fam Plann Reprod Health Care. 2016 Apr;42(2):93-8
pubmed: 26645197
Am J Obstet Gynecol. 2007 Apr;196(4):297-308
pubmed: 17403398
JAMA. 2006 Apr 19;295(15):1809-23
pubmed: 16622143
J Pregnancy Child Health. 2015 Oct;2(5):
pubmed: 27294202
N Engl J Med. 1999 Feb 25;340(8):589-94
pubmed: 10029642
Obstet Gynecol. 2019 Dec;134(6):1178-1185
pubmed: 31764727
Rev Bras Ginecol Obstet. 2016 Nov;38(11):545-551
pubmed: 27832675
Contraception. 2018 Jun;97(6):559-564
pubmed: 29490290